期刊文献+

膀胱癌尿脱落细胞Survivin蛋白表达的研究 被引量:1

Expression of surviving in bladder carcinoma
下载PDF
导出
摘要 目的探讨膀胱肿瘤尿脱落细胞中Survivin蛋白的表达与临床、病理特征的关系,以及在膀胱肿瘤诊断中的价值。方法用免疫组织化学方法(S-P法)检测膀胱肿瘤75例、腺性膀胱炎2例、正常对照10例的尿沉渣Survivin蛋白的表达。结果Survivin蛋白在对照组中无表达;腺性膀胱炎2例均表达;膀胱肿瘤组高表达,表达率96.00%,但与肿瘤的分期、分级无关(P>0.05)。尿脱落细胞学检查阳性率为34.67%。两者相比差异具有显著性(P<0.05)。结论Survivin蛋白在正常膀胱组织中不表达,癌前病变中可有表达,膀胱癌细胞中呈高表达。尿Survivin蛋白检测具有较高的敏感性和特异性,不失为膀胱肿瘤客观评价和早期诊断的重要指标。 Objective To investigate the expression of apoptosis inhibited gene Survivin in urine bladder tumors and relationship with pathological parameter, evaluate its application in diagnosis of bladder tumors. Methods The surviving was detected by immunohistochemical assay (S-P method) in urine sediments samples of the 75 cases of bladder tumor, 2 Glandulose cystitis, and 10 normal control. Results The Survivin was not express in the normal, positive expression in 2 example of Glandulose cystitis. Present the high expression in the urine bladder tumor, the positive rate was 96% (72/ 75). The expression was not related to tumor grade, stage, transferring, the positive rate was 34.67 % (26/75) of the urine cytology in urine sediment from 75 cases of bladder cancer. There was a sufficient difference between them (P〈0.05). Conclusion The protein of Survivin present high expression in the urine bladder tumor. The protein of Survivin in urine sediment has a high sensitivity and specialization, it can be used as a good maker on the objective evaluation and early diagnose for bladder carcinoma.
出处 《贵州医药》 CAS 2006年第6期497-499,共3页 Guizhou Medical Journal
基金 贵州省科技攻关项目(编号2001.1133)资助
关键词 SURVIVIN蛋白 膀胱癌 尿沉渣 免疫组化 Survivi Bladder cancer Urine sediment Immunohistochemistry
  • 相关文献

参考文献7

  • 1罗旭,李道兵,赵泽驹,梁国标,李栋.表皮生长因子在膀胱癌中的表达及意义[J].贵州医药,2003,27(4):294-295. 被引量:4
  • 2Sharp JD,Hausladen DA,Maker MG,et al.Bladder cancer detection withurinary survivin,an inhibitor of apoptosis[J].Front Biosci,2002,7 (2):E36-41.
  • 3陈必成,吴秀玲,张方毅,李澄棣.Survivin在膀胱移行细胞癌中的表达及意义[J].浙江医学,2002,24(6):324-325. 被引量:16
  • 4Schultz IJ,Kiemeney LA,Witjes JA,et al.Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence[J].Anticancer Res,2003,23(4):3 327-3 331.
  • 5Suzuki A,Hagashida M,Ito T,et al.Survivin initates cell cycle entry by the competitive interaction with CDK4/P 16(INK4a) and CDK2/cyclinE complex actiration[J].Oncogene,2000,19(29):3 225.
  • 6Suzuki A,Ito T,Kawano H,et al.Survivin intiates proca-spase3/P21 complex for mation as a result of interaction with CDK4 to rsist fas-mediated cell death[J].One-ogene,2000,19(10):1 346.
  • 7Lehner R,Lucia MS,Jarboe EA,et al.Immunhistochemical localization of the IAP protein surviving in bladder mucosa and transitional cell carcinoma[J].Appl-Immunohisto chem -Mol-Morphol,2002,10(2):134-138.

二级参考文献10

  • 1[1]Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma.Nat Med,1997, 3(8):917.
  • 2[2]Henk G.Van der Poel,Frans MJ.Can biological markers replace cystoscopy?Current Opinio in Urology, 2001,11:503.
  • 3[3]Adida C, Cortty PL,McGrath J,et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.Am J Pathol, 1998,152(1):43.
  • 4[4]Smith SD,Wheeler MA,Plescia J,et al.Urine detection of survivin and diagnosis of bladder cancer.JAMA, 2001,285 (3):324.
  • 5[5]Mesri M, Wall NR,Li J, et al. Cancer gene therapy using a survivin mutant adenovirus.J Clin Invest, 2001,108(7): 981.
  • 6[6]Sanuma K, Moriai R,Yanjima T.Survivin as a radioresistance factor in pancreatic cancer.Jpn J Cancer Res, 2000,91 (11):1204.
  • 7[7]Yagihashi A,Asanuma K,Nakamura M.Detection of anti-survivin antibody in gastrointestinaX cancer patients.Clin Chem, 2001,47 (9): 1729.
  • 8[1]Downward J,Yarder Y,Mayas E.Close similarity of epidermal growth factor receptor and C-erbB oncogene sequence.Nature,1984,307:529~531.
  • 9[2]Tanaka S.Immunoreactive transforming growth factor in colorectal adenomas and carcinomas.Oncology,1992,49(5):381~385.
  • 10[3]Tahara E.Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy.Jpn J Cancer Res,1986,77(2):145~147.

共引文献18

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部